Cure My Disease

Don't miss your cure!

 Log in / Sign up

A digital guide may cut long sick leave for workers with muscle and joint pain

NCT ID NCT07793526

Disease control Sponsor: Amsterdam UMC, location VUmc Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

This trial tests a computer-assisted reintegration protocol for employees on sick leave due to musculoskeletal disorders, such as back, neck, or shoulder pain. The protocol helps occupational health professionals follow national guidelines and Dutch law when guiding employees back to work. Researchers will measure how quickly participants return to work fully or partially, and whether the approach reduces sick-leave costs. The study includes 140 employees aged 18 to 65 who are at high risk of long-term sick leave.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A computer-assisted occupational reintegration protocol that guides occupational health professionals in supporting employees on sick leave due to musculoskeletal disorders.
What this could lead to
If it works, this protocol could shorten sick leave for employees with musculoskeletal disorders, reduce costs for employers, and improve return-to-work guidance across the Netherlands.
What could go wrong
This is a relatively small study, and the protocol's success depends on how well occupational health professionals adopt it. Results may not apply to all workplaces or types of musculoskeletal complaints.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Employees on sick leave due to musculoskeletal complaints receiving return-to-work guidance by a major occupational health service in The Netherlands

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18-65 years * Self-reported musculoskeletal complaints as primary reason for sick leave * High risk of long-term sick leave Exclusion Criteria: * Musculoskeletal complaints due to pregnancy * Retirement within one year * Sick leave duration of \>18 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Musculoskeletal disorders (MSDS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

musculoskeletal system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Musculoskeletal disorders (MSDS)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Arbo Unie

    RECRUITING

    Utrecht, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.